Ryan Altman has been named the Steve and Lee Ann Taglienti Chair in Pharmacy.
The termed professorship recognizes high-achieving faculty who have demonstrated excellence in both research and teaching, while also engaging in meaningful research collaborations.
Altman, a professor of medicinal chemistry and molecular pharmacology, is an internationally recognized scholar in synthetic organic with emphases in organometallic and organofluorine chemistry, and medicinal chemistry with emphasis in neurotherapeutic drug discovery. He also provides medicinal chemistry support for pharmacological collaborators to develop agents for treating pain, mood and anxiety disorders, aging, and inflammation.
Altman is one of the Purdue College of Pharmacy’s top National Institutes of Health-funded researchers.
According to Eric Barker, the Jeannie and Jim Chaney Dean of the College of Pharmacy, Altman is the right fit for the role.
“Dr. Altman’s outstanding record of scholarship and teaching make him an ideal candidate for this professorship,” Barker said. “We’re thrilled his role will carry the names of Steve and Lee Ann Taglienti whose contributions to the field of pharmacy and the college have been incredibly impactful.”
College of Pharmacy alumni Steve (BS ’89) and Lee Ann (BS ’89) Taglienti established the termed professorship in 2017 to enhance education quality by recruiting and retaining top faculty. They are the founders of Focus Medical Communications, a provider of medical education in specialty markets.
In addition to his research and teaching programs, Altman serves on Purdue’s Faculty Senate, Environmental Health and Safety Chemical and Laboratory Safety Committee, and Nuclear Magnetic Resonance Instrumentation Facility Executive Committee. Prior to joining the Purdue faculty in 2020, Altman spent more than nine years as an assistant, then associate, professor of medicinal chemistry at the University of Kansas.
Learn more about Altman’s research lab.